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Abstract 13 
Short-chain fatty acid (SCFAs) biosynthesis is pertinent to production of biofuels, industrial 14 
compounds, and pharmaceuticals from renewable resources. To expand on Escherichia coli 15 
SCFA products, we previously implemented a coenzyme A (CoA)-dependent pathway that 16 
condenses acetyl-CoA to a diverse group of short-chain fatty acyl-CoAs. To increase product 17 
titers and reduce premature pathway termination products, we describe in vivo and in vitro 18 
analyses to understand and improve the specificity of the acyl-CoA thioesterase enzyme, which 19 
releases fatty acids from CoA. A total of 62 putative bacterial thioesterases, including 23 from 20 
the cow rumen microbiome, were inserted into a pathway that condenses acetyl-CoA to an acyl-21 
CoA molecule derived from exogenously provided propionic or isobutyric acid. Functional 22 
screening revealed thioesterases that increase production of saturated (valerate), unsaturated 23 
(trans-2-pentenoate) and branched (4-methylvalerate) SCFAs compared to overexpression of E. 24 
coli thioesterase tesB or native expression of endogenous thioesterases. To determine if altered 25 
thioesterase acyl-CoA substrate specificity caused the increase in product titers, six of the most 26 
promising enzymes were analyzed in vitro. Biochemical assays revealed that the most productive 27 
thioesterases rely on promiscuous activity, but have greater specificity for product-associated 28 
acyl-CoAs than for precursor acyl-CoAs. Here we introduce novel thioesterases with improved 29 
specificity for saturated, branched and unsaturated short-chain acyl-CoAs, thereby expanding the 30 
diversity of potential fatty acid products while increasing titers of current products. The growing 31 
uncertainty associated with protein database annotations denotes this study as a model for 32 
isolating functional biochemical pathway enzymes in situations where experimental evidence of 33 
enzyme function is absent. 34 
  35 
3 
 
1. Introduction 36 
 The potential for producing biofuels, industrial compounds, and pharmaceuticals from 37 
renewable resources has led to an increased interest in short-chain (C2 – C7) fatty acid (SCFA) 38 
biosynthesis. Developing recombinant strains to produce these molecules could lead to 39 
production of polymers such as polyhydroxyalkanoates and pharmaceuticals such as statins from 40 
fossil fuel alternatives (1, 2). Supporting the development of microbially-synthesized products is 41 
the reduced cost and increased prevalence of genomic sequencing. The resulting profusion of 42 
metabolic diversity provides a wealth of potential enzymes with known genetic sequences for 43 
improving biosynthetic pathways. For example, recent genomic sequencing has unveiled the 44 
metabolic diversity of important members from the cow rumen microbiome, an environment rich 45 
in SCFAs (3, 4). These genome sequences provide an opportunity to find enzymes that improve 46 
production and specificity in SCFA biosynthesis pathways. 47 
One such pathway that would benefit from improved enzyme specificity is Coenzyme A 48 
(CoA)-dependent biosynthesis of SCFAs. In the CoA-dependent pathway, a thiolase enzyme 49 
condenses an acyl-CoA molecule with acetyl-CoA (Figure 1). The resulting 3-ketoacyl-CoA 50 
molecule is then sequentially reduced by reductase, crotonase, and enoyl-reductase enzymes 51 
before the 3-hydroxy, unsaturated, and saturated fatty acids, respectively, are cleaved from CoA 52 
using a thioesterase enzyme. Previous work from our lab has used this pathway with acetyl-CoA 53 
and glycolyl, propionyl, or isobutyryl-CoA as the condensed substrates to produce a variety of 54 
SCFAs using E. coli TesB including 3-hydroxyvalerate (3-hydroxypentanoate) (1), 55 
dihydroxybutyrate (5), 3-hydroxy-4-methylvalerate (5), and a variety of alcohols (6). One benefit 56 
of CoA-dependent biosynthesis of SCFAs is the diversity of potential products (7); however, 57 
with this diversity comes a need for selective enzymes that increase final product titers by 58 
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minimizing substrate flux to undesired byproducts. The selectivity of the final enzyme in the 59 
pathway, the thioesterase, is of particular importance because it influences the product profile by 60 
catalyzing fatty acid release from CoA at each step of the pathway (Figure 1) and is important 61 
for secretion of fatty acid products (8). While many acyl-ACP thioesterases have been 62 
investigated for improved fatty acid production, acyl-CoA thioesterases are not as well explored 63 
(8-10). Despite its preference for acyl-CoAs in the C14-C18 range (11), the E. coli acyl-CoA 64 
thioesterase TesB produces diverse SCFAs (12). However, locating more selective thioesterases 65 
may reduce byproduct formation and increase final product titers. 66 
 Selecting individual thioesterase enzymes for functional screening against short-chain 67 
fatty acyl-CoAs is challenging because much of their vast phylogenetic and functional diversity 68 
is poorly understood (13). While many thioesterases have been explored for long-chain fatty acid 69 
production (14-17), few studies have focused on those that prefer short-chain acyl-CoAs. Several 70 
broad specificity acyl-CoA thioesterases including E. coli TesB and Saccharomyces cerevisiae 71 
Pte1p can be used for SCFA production, but lack the specificity necessary for optimizing 72 
biosynthetic pathways (11, 18). One approach to selecting thioesterases for functional screening 73 
that improves the likelihood of finding enzymes with the desired specificity is to investigate 74 
those proteins with similarity to commonly used and effective enzymes. However, the absence of 75 
known selective short-chain acyl-CoA thioesterases restricts this approach. Sampling candidates 76 
more broadly will increase opportunities for finding enzymes with new substrate specificities, 77 
but will also increase the number of thioesterases with undesired activities. Some combination of 78 
these routes can be used to screen sufficient phylogenetic breadth while also increasing the 79 
sample size of TesB-like thioesterases to reveal enzymes with greater specificity for short-chain 80 
acyl-CoAs.  81 
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To address this need, we functionally screened 62 putative thioesterases in a pathway for 82 
production of the SCFAs 3-hydroxyvalerate, trans-2-pentenoate, valerate, and 4-methylvalerate 83 
in E. coli. Six enzymes were homologous to variants active on short-chain acyl-CoAs, while the 84 
remaining 56 represent all of the annotated thioesterases from five bacterial strains of interest. 85 
Based upon in vivo fatty acid titers of those recombinant strains, six enzymes were chosen for in 86 
vitro analysis on a broad range of acyl-CoAs to determine their substrate preferences. The 87 
combination of in vivo and in vitro data indicate that we have uncovered thioesterases with 88 
greater specificity for and production of unsaturated, saturated, and branched SCFAs in E. coli 89 
relative to TesB and endogenous thioesterase activity.  90 
 91 
2. Methods 92 
2.1. Bacterial Strains 93 
 Rumen isolate Prevotella ruminicola 23 was obtained from Dr. Roderick Mackie of the 94 
University of Illinois, Urbana-Champaign (USA). Genomic DNA from rumen isolates 95 
Fibrobacter succinogenes S85 and Ruminococcus albus 7 were obtained from Dr. Paul Weimer 96 
of the US Dairy Forage Research Center, USDA-Agricultural Research Service, Madison (USA). 97 
Alcanivorax borkumensis SK2 (ATCC# 700651) and genomic DNA from Pseudomonas 98 
aeruginosa PAO1 (ATCC# 47085) were purchased from the ATCC. Genomic DNA of 99 
Rhodopseudomonas palustris CGA009 was obtained from Dr. Caroline Harwood of the 100 
University of Washington, Seattle (USA). Pseudomonas syringae pv. maculicola ES4326 was 101 
obtained from Dr. Fred Ausubel at Massachusetts General Hospital (Boston, MA, USA). E. coli 102 
MG1655 (DE3) ΔendA ΔrecA was previously constructed in our lab (1). 103 
 104 
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2.2. Plasmid and Strain Construction 105 
 Plasmid pET/ter/bktB/pct was constructed previously (6) and plasmid pCDF/phaB/phaJ4 106 
was constructed by subcloning phaB from pET/bktB/phaB (5) into multiple cloning site I by 107 
NdeI/XhoI restriction digest and phaJ4 into multiple cloning site II of pCDFDuet-1 108 
(EMDmillipore) using primers listed in Table S1. Plasmid pET/bktB/pct was constructed from 109 
pET/ter/bktB/pct by BamHI/NotI restriction digest followed by treatment with Mung Bean 110 
Nuclease (New England Biolabs) and blunt ligation of the 8 kb fragment. 111 
Genomic DNA was isolated from bacterial strains using the Wizard Genomic DNA 112 
Purification Kit (Promega). Custom oligonucleotides were purchased for the PCR amplification 113 
of all individual thioesterases and CoA ligases from purified genomic DNA (Integrated DNA 114 
Technologies). Primers used for amplification are listed in Table S1. Following amplification, 115 
individual genes were inserted into the expression vector pACYCDuet-1 (EMDmillipore) using 116 
polymerase incomplete primer extension (PIPE)-based cloning (19). The genes encoding R. 117 
palustris CoA ligases FcsA (Rpa4267) and VcsA (Rpa3299) (20) and the genes encoding the six 118 
thioesterases chosen for further analysis were inserted into vector pTEV5 for protein purification 119 
using PIPE-based methods (21). The pTEV5 construct produced an enzyme with an N-terminal 120 
hexahistidine tag removable by TEV protease. Due to solubility problems in pTEV5, the genes 121 
encoding thioesterases Pr1687 and Fs2108 were amplified from genomic DNA and cloned using 122 
restriction enzymes NdeI and EcoRI into pTYB22 (New England Biolabs) which produced an 123 
enzyme with an N-terminal chitin-binding domain removable by intein self-cleavage. Plasmid 124 
sequences were confirmed using PCR amplification and DNA sequencing (GENEWIZ). 125 
Gene deletions of yciA, yigI, and tesB in E. coli MG1655 (DE3) ΔendA ΔrecA were made 126 
using P1 transduction with strains JW1245-1, JW5588-1, and JW0442-1, respectively, from the 127 
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Keio collection as donor cells (22). The kanamycin resistance gene was removed using FLP-128 
mediated recombination as previously described (23). 129 
 130 
2.3. Culture Conditions 131 
 Recombinant strains of E. coli MG1655 (DE3) ΔendA ΔrecA were grown at 30°C in 132 
Luria-Bertani (LB) medium overnight in a shaking incubator at 250 rpm. 50 µL of the overnight 133 
culture was used to inoculate a 50 mL LB culture supplemented with 10 g/L glucose containing 134 
100 mg/L ampicillin, 50 mg/L streptomycin, and, when pACYCDuet-1 was present, 16 mg/L 135 
chloramphenicol. Cultures were grown at 30°C until an optical density at 600 nM (OD600) of 0.8 136 
was reached, at which point isopropyl-β-D-1-thiogalactopyranoside (IPTG) was added to a final 137 
concentration of 1 mM with either propionate or isobutyrate to a final concentration of 15 mM. 138 
Cultures were incubated at 30°C for 48 h post-induction prior to fatty acid titer determination. 139 
 140 
2.4. Fatty Acid Analysis 141 
  Culture samples were centrifuged to pellet cells and culture supernatant was removed for 142 
HPLC analysis. A 5 µl sample of culture supernatant was injected into an Agilent 1100 series 143 
instrument equipped with refractive index detection (RID). Samples were processed through an 144 
Aminex® HPX-87H anion-exchange column (Bio-Rad Laboratories) with isocratic flow of 5 mM 145 
H2SO4 mobile phase at a rate of 0.6 mL/min and column and detector temperatures set to 35°C. 146 
Concentrations of valerate, 3-hydroxyvalerate, trans-2-pentenoate, and 4-methylvalerate were 147 
determined using linear regression of external standards. 148 
 149 
2.5. Protein Purification 150 
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 Acyl-CoA ligases FcsA and VcsA and thioesterases EcTesB, PpTesB, EcYdiI and Pr655 151 
were overproduced using pTEV5 constructs in E. coli BL21Star (DE3) (Invitrogen). One liter of 152 
cells were grown at 30°C in LB medium containing 100 mg/L ampicillin until an OD600 of 0.5 153 
was reached, at which point IPTG was added to the cultures at a concentration of 100 mg/L. Post 154 
induction, the cells were grown for 15 h at 30°C, then harvested by centrifugation and 155 
resuspended in 2.5x v/w Buffer A (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% v/v glycerol). 156 
Protein purification followed previously described protocols for nickel chelate chromatography 157 
followed by cleavage with TEV protease (24). Proteins were flash frozen in liquid nitrogen and 158 
the concentration was determined using the Bradford assay with bovine serum albumin as a 159 
standard (25) (Bio-Rad). 160 
 Pr1687 and Fs2108 protein was purified using the Intein-Mediated Purification with an 161 
Affinity Chitin-binding Tag (IMPACT) expression vector pTYB22 (New England Biolabs). 162 
Cells were grown and induced using the same conditions as described for pTEV5 constructs and 163 
proteins were purified with chitin-affinity chromatography followed by intein cleavage mediated 164 
by dithiothreitol (DTT) using previously described conditions (26). Proteins were stored and 165 
quantified as described for nickel chelate chromatography purified proteins. 166 
 167 
2.6. Enzymatic Synthesis of Acyl-CoAs 168 
 Acyl-CoA synthesis reactions were carried out in 50 mM HEPES pH 7.5, 1 mM DTT, 5 169 
mM MgCl2, 5 mM ATP, and 2 mM CoA. Fatty acid substrate was added at 7.5 mM for butyrate, 170 
3-hydroxyvalerate, trans-2-pentenoate, valerate, 4-methylvalerate, hexanoate, octanoate, 171 
decanoate, and dodecanoate while 2 mM fatty acid substrate was used for tetradecanoate. To 172 
increase solubility, 1% and 3% w/v triton-X 100 was added to reactions with dodecanoate and 173 
9 
 
tetradecanoate respectively. CoA ligase enzymes were added at 500 nM for all reactions. VcsA 174 
was added to butyrate, 3-hydroxyvalerate, valerate, 4-methylvalerate, and hexanoate reactions, 175 
while FcsA was added to octanoate, decanoate, dodecanoate, and tetradecanoate reactions. 176 
Reactions were run overnight at room temperature for all substrates except trans-2-pentenoate, 177 
which was run at 30°C for 6 h because these conditions reduced the appearance of degradation 178 
products. Acyl-CoA ligases were precipitated from reactions at 95°C for 5 min, and then 179 
removed by centrifugation.  180 
 Acyl-CoA products were purified from substrates using an Agilent 1200 series HPLC 181 
with diode array detection (DAD). A 100 µL reaction volume was injected onto an Agilent 182 
Eclipse XDB-C18 column and separation achieved using a mobile phase of 50 mM ammonium 183 
acetate, 0.1% m/v acetic acid (Solvent A) - 50 mM ammonium acetate, 0.1% m/v acetic acid, 184 
70% v/v acetonitrile (Solvent B) gradient. The method began at 100% Solvent A from 0-5 min, 185 
followed by a 0-100% gradient of solvent B from 5-50 minutes, followed by an isocratic step of 186 
100% solvent B from 50-55 min. The gradient was run at a flow rate of 1 mL/min and CoA was 187 
monitored by measuring absorbance at 258 nM. Fractions containing peaks corresponding to 188 
acyl-CoAs were collected, flash frozen in liquid nitrogen, and lyophilized. Dried acyl-CoAs were 189 
then resuspended in water and the concentration was determined by the absorbance at 258 nM 190 
using the molar extinction coefficient of CoA (14,328 M-1 cm-1) within the linear range of 191 
detection (27). 192 
 193 
2.7. Thioesterase Activity Assays 194 
 Thioesterase activity was measured using 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) 195 
which reacts with free CoA after it is released through thioesterase-mediated bond cleavage. 196 
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Reactions were carried out in 1 mM DTNB, 100 mM HEPES pH 8.0, 20 µM acyl-CoA and were 197 
run in the linear range of each thioesterase. Substrate concentrations matched those used 198 
previously for EcTesB analysis (11). Reaction progress was monitored through the change in 199 
absorbance at 412 nm using the molar extinction coefficient of 5-thio-2-nitrobenzoate (14,150 200 
M-1 cm-1), which is formed when DTNB reacts with free CoA (28). 201 
 202 
3. Results 203 
3.1 In Vivo Functional Screening for Thioesterases that Alter Fatty Acid Production 204 
 Acyl-CoA thioesterase substrate specificity plays an important role in deciding the SCFA 205 
profile produced using a CoA-based pathway. For example, if the target product is a saturated 206 
fatty acid, a thioesterase with broad substrate specificity will release fatty acids at each step in 207 
the biosynthetic pathway, depleting substrate pools and reducing the final product titer (Figure 208 
1). To find thioesterases that increase specificity for and production of 3-hydroxy, unsaturated, 209 
saturated and branched fatty acids in the pathway, 62 putative thioesterases were chosen for 210 
screening. A group of six thioesterases, three TesB and three TesB2 enzymes, were chosen that 211 
had 38-50% amino acid identity to E. coli MG1655 TesB (EcTesB), which makes 3-hydroxy and 212 
saturated fatty acids in vivo (1, 6, 29), and 40-41% amino acid identity to A. borkumensis TesB2 213 
enzyme, which was previously described as having specificity for 3-hydroxy acyl-CoAs (30) 214 
(Table 1). 215 
 To incorporate greater phylogenetic and functional diversity of thioesterases, the 216 
remaining 56 proteins encompassed all of the annotated thioesterases from five bacterial strains 217 
(Table 1). E. coli MG1655 (Accession: NC_000913.2) thioesterases were chosen with the dual 218 
purpose of identifying those that increase product titers of desired SCFAs for use in heterologous 219 
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pathways and those that reduce product titers and should be targeted for deletion from our host 220 
strain. The second source of thioesterases, Pseudomonas putida KT2440 (Accession: 221 
NC_002947.3), was chosen for its phylogenetic similarity to E. coli and because it is a known 222 
producer of polyhydroxyalkanoates, which may indicate the presence of thioesterases with 223 
specificity to 3-hydroxy acyl-CoAs (31). The remaining three organisms, Prevotella ruminicola 224 
23 (Accession: NC_014033.1), Fibrobacter succinogenes S85 (Accession: NC_017448.1), and 225 
Ruminococcus albus 7 (Accession: NC_014833.1), were chosen because they are prevalent in the 226 
cow rumen microbiome and contribute to the high concentrations of SCFAs found there (3, 4, 227 
32).  228 
Each of the 62 putative thioesterases was individually overexpressed in E. coli containing 229 
all the necessary genes for CoA-dependent biosynthesis of valerate (Figure 1). Previous work 230 
from our lab identified Treponema denticola Ter, Megaphaera elsdenii Pct, and Cupriavidus 231 
necator (formerly R. eutropha H16) BktB, PhaB, and PhaJ4 as suitable upstream pathway 232 
enzymes for valerate production (6, unpublished data). Cells were grown in LB containing 233 
glucose until log phase growth, then pathway genes were induced and cultures were 234 
supplemented with either propionate or isobutyrate for straight or branched SCFA biosynthesis, 235 
respectively (Figure 1). LC-based analysis of the culture supernatant was used to screen for 236 
enzymes that altered the fatty acid product profiles. Specifically, the resulting chromatograms 237 
were examined for increases and decreases of 3-hydroxyvalerate, trans-2-pentenoate, valerate, 238 
and 4-methylvalerate. Profiles produced by recombinant strains were compared to controls with 239 
either no recombinant thioesterase or with overproduced EcTesB, a thioesterase used previously 240 
in our group (1, 5, 6). 241 
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Overproduction of greater than 20% of the thioesterases functionally screened in this 242 
study resulted in observable changes in substrate, intermediate, and product titers relative to the 243 
control strains (Table S2). Four thioesterases, EcYciA, Pp1466, Pp3807, and Pp4975, were 244 
associated with significant reduction in valerate and 4-methylvalerate production combined with 245 
increased acetate and propionate titers (Table S2). Two thioesterases, Pr1510 and Fs368, were 246 
associated with a production phenotype involving reduced titers of measured substrates, 247 
intermediates, and final products combined with increased glucose consumption (Table S2). The 248 
most logical explanation for this phenotype is channeling of substrates to long-chain fatty acid 249 
biosynthesis. Because long-chain fatty acids could not be quantified with our HPLC system, 250 
additional experiments outside the scope of this work are required to determine the activity 251 
profile of these enzymes. 252 
 253 
3.2 Host Strain Development and Identification of Thioesterases for In Vitro Analysis 254 
From the 12 annotated E. coli thioesterases screened during this study, three were chosen 255 
for deletion from the host strain. The tesB gene was deleted because its overexpression resulted 256 
in increased titers of 3-hydroxyvalerate, which could be a final product, but also acts as a shunt 257 
product in the formation of trans-2-pentenoate or valerate; yciA was deleted because its 258 
overexpression increased final titers of the precursor-derived and exogenously supplied acids 259 
acetate and propionate, which correlates with previous work (33), while decreasing final product 260 
titers of valerate and 4-methylvalerate; and yigI was deleted because its overexpression resulted 261 
in decreased production of 4-methylvalerate and increased final acetate and isobutyrate titers. 262 
The resulting triple thioesterase deletion strain E. coli MG1655 (DE3) ΔendA ΔrecA ΔtesB 263 
ΔyciA ΔyigI was used for further in vivo analysis of several active thioesterases. 264 
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From the full set of 62 functionally screened thioesterases, EcTesB, PpTesB, EcYdiI, 265 
Fs2108, Pr655, and Pr1687 were chosen for more detailed in vivo and in vitro analysis because 266 
their overproduction resulted in increased titers of 3-hydroxyvalerate, trans-2-pentenoate, 267 
valerate, or 4-methylvalerate. Propionate and isobutyrate feeding experiments were performed in 268 
triplicate with these six thioesterases in both E. coli MG1655 (DE3) ΔendA ΔrecA and the triple 269 
thioesterase deletion strain containing pET/ter/bktB/pct and pCDF/phaB/phaJ4 in an effort to 270 
distinguish recombinant thioesterase activity from background and potentially increase final 271 
product titers (Figure 2a, b). The greatest 3-hydroxyvalerate titers were produced in recombinant 272 
strains overproducing TesB enzymes from E. coli and P. putida when compared with the other 273 
60 putative thioesterases (Figure 2). The maximum titer (2.163 g/L) resulted from 274 
overproduction of EcTesB (Table 2), and is similar to previously published titers from our lab 275 
(1). 3-hydroxyvalerate titers were 20% lower in the triple deletion strain overproducing EcTesB 276 
than in E. coli with native thioesterases.  277 
Observable titers of unsaturated SCFAs were uncommon among the recombinant strains 278 
with only Pr655 overproduction resulting in detectable trans-2-pentenoate during initial 279 
screening (Figure 2a, b). To determine whether strains containing the other five thioesterases 280 
selected for further analysis could produce detectable unsaturated SCFAs in vivo, each was 281 
introduced into a strain lacking the downstream enoyl-reductase gene ter, which does not 282 
produce the favored substrate valeryl-CoA (Figure 2c, d). In these recombinant strains, product 283 
titers of trans-2-pentenoate were greatest for EcYdiI, Pr655, and Pr1687, with EcYdiI 284 
overproduction resulting in the greatest trans-2-pentenoate titer, 695 mg/L (Table 2). To our 285 
knowledge, this is the largest published titer of an unsaturated SCFA from an engineered 286 
pathway in E. coli.  287 
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Three thioesterases, Fs2108, Pr1687, and EcYdiI, were chosen for further analysis 288 
because their overproduction increased titers of the saturated acids valerate and 4-methylvalerate 289 
while decreasing shunt product titers (Figure 2a, b). Overproduction of thioesterase Fs2108 290 
achieves the greatest final titers for both the straight SCFA valerate and the branched SCFA 4-291 
methylvalerate (Table 2) with 3-hydroxy and unsaturated fatty acid intermediate titers below the 292 
limit of detection. While overproduction of Fs2108 resulted in a modest 15% improvement in 293 
valerate titer over the EcTesB control, an improvement of greater than 200% was observed for 4-294 
methylvalerate titer over the same control. This 200% improvement was possible in part because 295 
4-methylvalerate titers were significantly lower than valerate titers for all 62 thioesterases tested, 296 
leaving more room for improvement. Overproduction of Fs2108 in the deletion strain resulted in 297 
approximately 10% more valerate and 30% more 4-methylvalerate than in the host containing all 298 
native thioesterases, which likely results from reduced hydrolysis of 3-hydroxyacyl-CoA and 299 
trans-2-acyl-CoA precursors. No 4-methylvalerate production was observed from the triple 300 
deletion strain when isobutyrate was supplied without thioesterase overexpression, which 301 
indicates that the remaining native thioesterases have poor activity on 4-methylvaleryl-CoA 302 
(Figure 2a, b). 303 
 304 
3.3 Determination of In Vitro SCFA Substrate Specificity for Active Thioesterases  305 
To determine the substrate preferences for the selected thioesterases, all six were 306 
overexpressed in E. coli BL21Star (DE3) and purified. Overexpression of Pr1687 and Fs2108 307 
required the use of a vector that inserted an N-terminal chitin binding domain to obtain soluble 308 
protein. EcTesB, PpTesB, EcYdiI, and Pr655 were soluble with an N-terminal hexahistidine tag. 309 
Thioesterases were then tested for in vitro acyl-CoA hydrolysis activity on 20 µM acetyl-CoA, 310 
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butyryl-CoA, valeryl-CoA, hexanoyl-CoA, octanoyl-CoA, decanoyl-CoA, dodecanoyl-CoA and 311 
tetradecanoyl-CoA using an Ellman’s reagent-based assay described previously for determining 312 
specific activity (11) (Figure 3a). EcTesB, Fs2108 and Pr1687 showed a preference for longer-313 
chain acyl-CoAs. PpTesB also showed a preference for longer acyl-CoAs, but the relationship 314 
was less linear than for EcTesB, Fs2108 and Pr1687. Pr655 showed a strong preference for 315 
butyryl and valeryl-CoAs and activity on acyl-CoAs longer than hexanoyl-CoA was below the 316 
limit of detection for this assay. EcYdiI had low activity for all substrates tested. A recent 317 
publication showing that EcYdiI has strong activity on the aromatic compound 1,4-dihydroxy-2-318 
naphthoyl-CoA provides justification for the weak activity of this enzyme on the substrates 319 
provided in this study (34). 320 
Specific activities were also measured for all six thioesterases on 3-hydroxy, unsaturated, 321 
saturated, and branched valeryl-CoAs (Figure 3b). For 3-hydroxyvaleryl-CoA, EcTesB and 322 
PpTesB had 6-fold greater specific activity than the next best thioesterase. Both EcYdiI and 323 
Pr655 showed low activity for 3-hydroxyvaleryl-CoA, while specific activity of Fs2108 and 324 
Pr1687 for the same substrate was below the limit of detection. No thioesterase had specific 325 
activity greater than 2 µM CoA min-1 mg protein-1 on trans-2-pentenoyl-CoA. Pr655, EcTesB, 326 
PpTesB, and EcYdiI displayed similar specific activities for this substrate; however, the small 327 
differences in specific acitivity translated into significant deviations in trans-2-pentenoate 328 
product titers when the thioesterases were overproduced in recombinant strains lacking the 329 
downstream enzyme Ter (Figure 3b). Fs2108 and Pr1687 specific activity on trans-2-pentenoyl-330 
CoA was below the limit of detection, but in vivo product profiles of strains lacking ter reflect a 331 
slight preference for 3-hydroxyvaleryl-CoA over trans-2-pentenoyl-CoA (Figure 2d). 332 
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All six enzymes selected for further analysis had detectable activity on valeryl-CoA; 333 
however, EcTesB, PpTesB, Pr655 and Fs2108 had much greater activity relative to EcYdiI and 334 
Pr1687 (Figure 3b). Activity against the 4-methylvaleryl-CoA (branched) substrate was greater 335 
than or equal to activity on straight valeryl-CoA for EcTesB, PpTesB, Fs2108, and Pr1687. 336 
EcYdiI and Pr655 both showed weak activity against 4-methylvaleryl-CoA. In vitro analysis of 337 
the enzymes associated with the greatest titers of valerate revealed that Fs2108 had greater 338 
specific activity for both valeryl-CoA and 4-methylvaleryl-CoA than either Pr1687 or EcYdiI 339 
(Figure 3b). Further, Fs2108 specific activity for both 3-hydroxyvaleryl-CoA and trans-2-340 
pentenyl-CoA precursors was below the limit of detection for in vitro assays. The greater 341 
specific activity of Fs2108 on 4-methylvaleryl-CoA and valeryl-CoA combined with reduced 342 
specific activity on precursor acyl-CoAs likely accounts for the increased 4-methylvalerate and 343 
valerate titers found for Fs2108. 344 
 345 
4. Discussion 346 
 In this study, 62 putative thioesterases were screened for increased product titers of 3-347 
hydroxy, unsaturated, saturated and branched products of interest. From these, six were chosen 348 
for more thorough in vivo and in vitro analysis. Relating the specific activity profiles of EcTesB, 349 
PpTesB, EcYdiI, Fs2108, Pr655 and Pr1687 with their in vivo product profiles of 3-350 
hydroxyvalerate, trans-2-pentenoate, valerate, or 4-methylvalerate leads to several important 351 
conclusions. First, the enzymes with the greatest in vivo product titers always had lower specific 352 
activity for the associated acyl-CoA than for alternative CoA substrates. For example, Fs2108 353 
has a six-fold higher specific activity for tetradecanyl-CoA than for valeryl-CoA indicating that 354 
valeryl-CoA is not the enzyme’s preferred substrate. The disparity between the specific activities 355 
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of Fs2108 for these two substrates indicates that our pathway relies on the promiscuous 356 
thioesterase activity of Fs2108. This is particularly evident for two thioesterases, EcYdiI and 357 
Pr1697, that were associated with increased valerate production despite having much higher 358 
specific activity for long-chain acyl-CoAs in the case of Pr1687, or aromatic acyl-CoAs for 359 
EcYdiI (34). The fact that all six thioesterases that were investigated in vitro prefer alternate 360 
substrates over those provided in our pathways suggests that both protein engineering and future 361 
bioprospecting efforts could further improve on the short-chain fatty acyl-CoA thioesterases 362 
discovered here.  363 
Comparing the in vivo product titers with in vitro substrate specificities of the six chosen 364 
thioesterases also suggests that after a specific activity level of 1-5 µM CoA min-1 mg protein-1 is 365 
reached for a given acyl-CoA, the enzyme’s activity for the pathway precursor acyl-CoAs 366 
becomes an important factor influencing final product titer, illustrating the importance of 367 
selecting pathway thioesterases with reduced activity on precursor acyl-CoAs. For example, 368 
strains overproducing thioesterases Pr1687 and EcYdiI produce more valerate than those 369 
overproducing EcTesB despite EcTesB having 30-fold greater specific activity for valeryl-CoA 370 
than Pr1687 and EcYdiI (Figure 2b). Accounting for this difference is the observation that 371 
EcTesB also has strong specific activity on the precursor 3-hydroxyvaleryl-CoA that translates 372 
into 3-hydroxyvalerate production while Pr1687 does not have detectable activity on 3-373 
hydroxyvaleryl-CoA. Further supporting the importance of reduced specific activity on pathway 374 
precursors is the observation that recombinant strains overproducing Pr655 produce much less 375 
valerate than strains overproducing EcYdiI and Pr1687 (Figure 2a, b) even though Pr655 376 
maintains greater specific activity for valeryl-CoA than thioesterases EcYdiI and Pr1687 (Figure 377 
3b). The increased specific activity of Pr655 on 3-hydroxyvaleryl-CoA and trans-2-pentenoyl-378 
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CoA precursors relative to EcYdiI and Pr1687 suggests that the reduced valerate titer results 379 
from increased precursor acyl-CoAs hydrolysis.  380 
Confounding our conclusion that thioesterases with low specific activity on precursor 381 
acyl-CoAs have improved final product titers is the observation that recombinant strains 382 
overexpressing ydiI produce high valerate titers with trans-2-pentenoate titers below the limit of 383 
detection despite EcYdiI exhibiting higher in vitro specific activity for 20 µM trans-2-pentenoyl-384 
CoA than for 20 µM valeryl-CoA (Figures 2a, 3b). In our recombinant strains, EcYdiI and the 385 
other screened thioesterases are competing with the downstream pathway enzyme Ter for the 386 
substrate trans-2-pentenoyl-CoA.  One plausible explanation for the absence of detectable trans-387 
2-pentenoate from this recombinant strain is that EcYdiI has a Km, a measure of substrate 388 
affinity, for both trans-2-pentenoyl-CoA and valeryl-CoA greater than the 20 µM concentration 389 
used in our in vitro assay, which is reasonable to assume because EcYdiI has evolved for 390 
specificity towards aromatic acids (34). If Ter has a lower Km for trans-2-pentenoyl-CoA than 391 
EcYdiI, then it could reduce the intracellular concentration of trans-2-pentenoyl-CoA below 20 392 
µM, causing EcYdiI activity for this compound to become physiologically irrelevant. In this 393 
situation, the intracellular valeryl-CoA concentration could increase to a point where low-level 394 
specific thioesterase activity would result in significant valerate production. Pr655, on the other 395 
hand, could have a lower Km for both trans-2-pentenoyl-CoA and valeryl-CoA, which would 396 
compete more effectively for the trans-2-pentenoyl-CoA with downstream enzyme Ter and allow 397 
continued low level production of trans-2-pentenoate (Figure 2a). Determination of kinetic 398 
parameters for these non-cognate substrates is limited by the low concentrations of acyl-CoAs 399 
obtained from enzymatic synthesis and LC-based purification.  400 
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The thioesterase substrate preferences found by our in vitro experiments indicate the 401 
breadth of thioesterase functional diversity screened in this study and underline the importance 402 
of sampling in the selection of pathway enzymes (Figure 3a and b). The TesB enzymes of E. coli 403 
and P. putida represent the most phylogenetically (50% amino acid identity) and functionally 404 
(Figure 3a and b) similar enzymes, while the remaining four thioesterases appear both 405 
phylogenetically and functionaly disparate. The TesB thioesterases showed both similar in vivo 406 
product profiles and in vitro specific activity profiles, which suggests that future screens aimed at 407 
acquiring more diverse TesB function should sample enzymes with lower similarity at the amino 408 
acid level than the E. coli and P. putida homologs. The diversity of the remaining 60 thioesterase 409 
phenotypes is an indication of the functional diversity inherent to bacterial thioesterases and 410 
suggests that many opportunities remain for isolating enzymes with improved specificity over 411 
those currently used in CoA-dependent biosynthetic pathways.  412 
Our study also highlights the challenges associated with enzyme selection for metabolic 413 
pathways. A common route to selecting pathway enzymes is to rely on proposed function of 414 
known enzymes in databases and the literature or choose enzymes homologous to those with 415 
proposed functions. Unfortunately, enzyme annotation in public databases has degraded as 416 
functional analysis has not kept up with the rate of sequence deposition (35). The absence of 417 
credible studies on short-chain acyl-CoA thioesterases prompted us to implement a broad 418 
functional screen of diverse candidates. Our results demonstrate the power of a well-designed 419 
screen for isolating uncharacterized or poorly characterized enzymes that improve product titers. 420 
Our methods for screening and in vitro characterization of substrate specificity serve as a 421 
template for investigating other poorly characterized enzyme functions for pathway 422 
development. The E. coli thioesterase EcYdiI serves as an example of an enzyme whose 423 
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documented function may eliminate it from contention (34), but once included in our functional 424 
screen, maintains the appropriate levels of promiscuous activity in intracellular conditions to 425 
provide the highest specificity for unsaturated SCFAs discovered so far. It is unlikely that 426 
selecting enzymes based solely upon annotated function would have identified this level of 427 
activity because short-chain acyl-coA thioesterase activity remains poorly characterized. 428 
During this study we isolated acyl-CoA thioesterases from diverse bacterial sources that 429 
increase production of saturated, unsaturated, and branched SCFAs through improvements in 430 
acyl-CoA substrate specificity. By comparing in vivo product profiles with in vitro specific 431 
activities of thioesterases that produced the greatest 3-hydroxyvalerate, trans-2-pentenoate, 432 
valerate, and 4-methylvalerate titers, we discovered that the most productive thioesterases found 433 
during functional screening: 1) use promiscuous activity to produce the SCFAs monitored in this 434 
study and 2) maintain low specific activity for pathway precursors relative to the preferred acyl-435 
CoA. These findings indicate this study as a model for isolating enzymes for biochemical 436 
pathway functions that are poorly characterized in the literature. Further, the thioesterases we 437 
identified provide opportunities for increasing titers of desirable products as well as developing 438 
new pathways for the production of unsaturated SCFAs. We have also provided important in 439 
vivo and in vitro data on the production phenotypes and substrate specificities of poorly 440 
characterized acyl-CoA thioesterases for short-chain acyl-CoAs that are valuable for future 441 
bioprospecting and engineering studies.  442 
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 553 
Figures. 554 
 555 
Figure 1. Biochemical pathway and LC-based in vivo screen for thioesterases with improved 556 
substrate specificity. The pathway in E. coli for the biosynthesis of SCFAs contains enzymes Pct 557 
(Megaphaera elsdenii), BktB (Cupriavidus necator), PhaB (Cupriavidus necator), PhaJ4 558 
(Cupriavidus necator), and Ter (Treponema denticola) with varied thioesterases. The dashed 559 
bond indicates the additional carbon incorporated into the fatty acids with feeding of isobutyrate 560 
in place of propionate. 561 
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 562 
Figure 2. In vivo fatty acid production. Titers of fatty acids produced from (a,c) E. coli MG1655 563 
(DE3) ΔendA ΔrecA and (b,d) E. coli MG1655 (DE3) ΔendA ΔrecA ΔtesB ΔyciA ΔyigI 564 
expressing CoA-based pathways for the biosynthesis of (a,b) valerate or 4-methylvalerate, (c,d) 565 
trans-2-pentenoate, with six different thioesterases. The product titers shown were obtained from 566 
three separate shake flasks for each thioesterase with error bars representing standard deviations. 567 
Each strain contained plasmids pCDF/phaB/phaJ4 with either (a,b) pET/ter/bktB/pct or (c,d) 568 
pET/bktB/pct. Each strain also contained plasmid pACYCDuet-1 with the thioesterases displayed 569 
on the X-axis. Absence of product bars for a thioesterase indicates that titers were below the 570 
limit of detection for the HPLC RID detector. 571 
*4-methylvalerate titers were determined using three separate cultures for each thioesterase fed 572 
15 mM isobutyrate in the place of propionate. 573 
 574 
Figure 3. Acyl-CoA specificity of six active thioesterases. (a) In vitro specific activity of six 575 
thioesterases on C2-C14 acyl-CoAs. Specific activities represent the average from three 576 
enzymatic reactions with error bars representing standard deviations. They were determined in 577 
the linear range for each thioesterase with acyl-CoA concentrations of 20 µM for C2, acetyl-578 
CoA; C4, butyryl-CoA; C5, valeryl-CoA; C6, hexanoyl-CoA; C8, octanoyl-CoA; C10, decanoyl-579 
CoA; C12, dodecanoyl-CoA; C14, tetradecanoyl-CoA. (b) In vitro specific activity of six 580 
thioesterases on saturated, valeryl-CoA; branched, 4-methylvaleryl-CoA; 3-hydroxy, 3-581 
hydroxyvaleryl-CoA; unsaturated, trans-2-pentenoyl-CoA. Inset is enlarged activities of EcYdiI 582 
and Pr655 for comparison of low level activities. Specific activities were determined using the 583 
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same conditions described in (a). The absence of a bar for a given substrate/thioesterase specific 584 
activity indicates that the activity was below the limit of detection at absorbance of 412 nm. 585 
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